UOC
CME icon

UBS O'Connor’s CME Group CME Stock Holding History

UBS O'Connor’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,000
Closed -$2.69M – 643
2022
Q4 		$2.69M Hold
16,000
– – 0.05% 339
2022
Q3 		$2.83M Buy
16,000
+11,000
+220% +$2.17M 0.03% 452
2022
Q2 		$1.02M Buy
+5,000
New +$1.06M 0.01% 761
2021
Q2 		– Sell
-15,000
Closed -$3.06M – 889
2021
Q1 		$3.06M Buy
+15,000
New +$2.95M 0.04% 371
2017
Q4 		– Sell
-33,700
Closed -$4.57M – 308
2017
Q3 		$4.57M Buy
+33,700
New +$4.26M 0.07% 200
2016
Q1 		– Sell
-18,000
Closed -$1.63M – 461
2015
Q4 		$1.63M Sell
18,000
-41,198
-70% -$3.88M 0.01% 340
2015
Q3 		$5.49M Buy
59,198
+26,142
+79% +$2.48M 0.05% 277
2015
Q2 		$3.08M Buy
+33,056
New +$3.08M 0.03% 359

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

UBS O'Connor's CME Position: Q1 2023 in Review

UBS O'Connor sold out of CME Group (CME) in Q1 2023, closing a stake of 16,000 shares — an estimated $2.69M sold.

UBS O'Connor first reported a position in CME in Q2 2015 and held it in 8 quarters. The position peaked at $5.49M in Q3 2015. 1,172 funds tracked by Wall St. Rank hold CME as of Q1 2023.

  • UBS O'Connor reported no remaining CME Group position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 16,000 CME Group shares in Q1 2023, an estimated $2.69M.
  • UBS O'Connor first reported a position in CME Group in Q2 2015 and held it in 8 quarters.
  • UBS O'Connor's CME Group position peaked at $5.49M in Q3 2015.
  • 1,172 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.